BIOLAB is a wholesaler in Waterloo. Public Limited, started on 17 August 1998, 1 establishment.

What is the address of BIOLAB?

The registered office of BIOLAB is located at Chaussée de Louvain 273 box 2, 1410 Waterloo.

Is BIOLAB still active?

Yes. According to the CBE (31 October 2026) BIOLAB is active, legal situation “Normale toestand”, started on 17 August 1998.

Is BIOLAB registered on Peppol?

Yes, BIOLAB is registered on the Peppol network with ID 0208:0463995639.

What is the enterprise number of BIOLAB?

The enterprise number of BIOLAB is BE0463995639.

When was BIOLAB founded?

BIOLAB was founded on 17 August 1998.

Who are the directors of BIOLAB?

According to the 2025 annual accounts, the directors of BIOLAB are: Isabelle Deroulede, Jean-Max DURAFFOURD.

Is BIOLAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 August 1998; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did BIOLAB make in 2025?

BIOLAB posted a profit after taxes of € 228,545 in financial year 2025.

What is the revenue of BIOLAB?

As a small company, BIOLAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 441,933.

How much does an employee at BIOLAB earn?

The average wage cost per full-time employee at BIOLAB was € 82,400 in 2025: staff costs of € 123,557 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BIOLAB have?

According to the 2025 annual accounts, BIOLAB has 1.5 full-time equivalents (FTE).

BIOLAB (Public Limited) - Waterloo - BE0463995639

Dossier BIOLAB, printed on 31 October 2026 from databakkes.be/en/0463995639/biolab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

30 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

BIOLAB from Waterloo, company number BE0463995639, closed financial year 2025 with a result of € 228,545 after tax. For that financial year BIOLAB recorded a gross margin of € 441,933 and equity of € 220,529. Compared with financial year 2024, the result moved from € 374,895 to € 228,545. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 24, 2026.

What it is worth Healthy

€ 220,529

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 228,545

▼ 39% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 526,932

▼ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 238,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

1.5

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 123,557

▼ 7% vs 2024

€ 82,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 44,094

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 39,056

€ 7,463 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 137,957

▲ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 20,014

▼ 41% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 203,641 Gross margin 2022: € 203,641 First fiscal year in the series	€ 579,577 Gross margin 2023: € 579,577 ▲ 185% vs 2022 (€ 203,641) Favourable step	€ 580,502 Gross margin 2024: € 580,502 Unchanged (€ 579,577) Favourable step	€ 441,933 Gross margin 2025: € 441,933 ▼ 24% vs 2024 (€ 580,502) Unfavourable step	▼ 24%
Profit after taxes	€ 117,071 Profit after taxes 2022: € 117,071 First fiscal year in the series	€ 447,547 Profit after taxes 2023: € 447,547 ▲ 282% vs 2022 (€ 117,071) Favourable step	€ 374,895 Profit after taxes 2024: € 374,895 ▼ 16% vs 2023 (€ 447,547) Unfavourable step	€ 228,545 Profit after taxes 2025: € 228,545 ▼ 39% vs 2024 (€ 374,895) Unfavourable step	▼ 39%
Equity	€ 88,042 Equity 2022: € 88,042 First fiscal year in the series	€ 285,589 Equity 2023: € 285,589 ▲ 224% vs 2022 (€ 88,042) Favourable step	€ 230,484 Equity 2024: € 230,484 ▼ 19% vs 2023 (€ 285,589) Unfavourable step	€ 220,529 Equity 2025: € 220,529 ▼ 4% vs 2024 (€ 230,484) Unfavourable step	▼ 4%
Total debts	€ 318,445 Total debts 2022: € 318,445 First fiscal year in the series	€ 409,748 Total debts 2023: € 409,748 ▲ 29% vs 2022 (€ 318,445) Unfavourable step	€ 639,811 Total debts 2024: € 639,811 ▲ 56% vs 2023 (€ 409,748) Unfavourable step	€ 638,450 Total debts 2025: € 638,450 Unchanged (€ 639,811) Favourable step
Cash	€ 320,810 Cash 2022: € 320,810 First fiscal year in the series	€ 598,673 Cash 2023: € 598,673 ▲ 87% vs 2022 (€ 320,810) Favourable step	€ 829,745 Cash 2024: € 829,745 ▲ 39% vs 2023 (€ 598,673) Favourable step	€ 526,932 Cash 2025: € 526,932 ▼ 36% vs 2024 (€ 829,745) Unfavourable step	▼ 36%
Retained profit	€ 26,069 Retained profit 2022: € 26,069 First fiscal year in the series	€ 223,615 Retained profit 2023: € 223,615 ▲ € 197,547 vs 2022 (€ 26,069) Favourable step	€ 168,511 Retained profit 2024: € 168,511 ▼ 25% vs 2023 (€ 223,615) Unfavourable step	€ 158,556 Retained profit 2025: € 158,556 ▼ 6% vs 2024 (€ 168,511) Unfavourable step	▼ 6%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 250,000 Dividend 2023: € 250,000 ▲ 150% vs 2022 (€ 100,000) Unchanged	€ 430,000 Dividend 2024: € 430,000 ▲ 72% vs 2023 (€ 250,000) Unchanged	€ 238,500 Dividend 2025: € 238,500 ▼ 45% vs 2024 (€ 430,000) Unchanged	▼ 45%
Bank debt	€ 6,617 Bank debt 2022: € 6,617 First fiscal year in the series	€ 515 Bank debt 2023: € 515 ▼ 92% vs 2022 (€ 6,617) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 515) Favourable step	€ 39,056 Bank debt 2025: € 39,056 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 413,687 Balance sheet total 2022: € 413,687 First fiscal year in the series	€ 702,537 Balance sheet total 2023: € 702,537 ▲ 70% vs 2022 (€ 413,687) Unchanged	€ 870,295 Balance sheet total 2024: € 870,295 ▲ 24% vs 2023 (€ 702,537) Unchanged	€ 858,980 Balance sheet total 2025: € 858,980 ▼ 1% vs 2024 (€ 870,295) Unchanged	▼ 1%
Employees (FTE)	-	-	1.6 Employees (FTE) 2024: 1.6 First fiscal year in the series	1.5 Employees (FTE) 2025: 1.5 ▼ 0.1 vs 2024 (1.6) Unchanged	▼ 0.1

Key figures of BIOLAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to BIOLAB?

What happened at BIOLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 24, 2026 New annual accounts for financial year 2025: profit of € 228,545 (▼ 39% vs 2024). Source: NBB ↗
2026 Isabelle Deroulede stepped down as director. NBB
2026 Jean-Max DURAFFOURD stepped down as director. NBB
2020 Isabelle Deroulede became a director. NBB
2020 Jean-Max DURAFFOURD became a director. NBB
Oct 7, 1999 New establishment in Waterloo. KBO
Aug 17, 1998 Start of the company according to the CBE. KBO

In short

From € 117,071 profit in 2022 to € 228,545 profit in 2025.

Paid € 221,991 in corporate taxes since 2022.

Best year ever: 2023, with € 447,547 profit.

On average € 294,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Isabelle Deroulede

Managing director

since 2020 · until 2026

Jean-Max DURAFFOURD

Director

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Louvain 273 box 2

1410 Waterloo

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 30 companies are registered at this address.

All companies at this address →

Photographers International

€ 22,038 gross margin · 2025

BROKERS ALLIED

€ 3,262 gross margin · 2025

GENVAL 14

€ 128,332 gross margin · 2025

Nagasha Immo

€ 40,421 gross margin · 2025

IMMOBILIERE EDEN

€ 25,591 gross margin · 2025

+25 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0463.995.639

VAT number

BE 0463.995.639

Registered office

Chaussée de Louvain 273 bus 2, 1410 Waterloo

Names & denominations

BIOLAB

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

17 August 1998

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Groothandel in parfumerieën en cosmetica

Bemiddelingsactiviteiten voor de gespecialiseerde detailhandel

Vervaardiging van andere voedingsmiddelen, neg

Vervaardiging van parfums en toiletartikelen

Vervaardiging van gehomogeniseerde voedingspreparaten en dieetvoeding

View on CBE Public ↗ Annual accounts (NBB) ↗